Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.

about

Cell Cycle Control by PTEN.Modeling Endometrial Cancer: Past, Present, and Future Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas Patient-Derived Xenograft Models for Endometrial Cancer Research

P2860

Q39365401-77E7DDF2-C16B-4832-81B1-809EDA31E47C Q57170070-308C2D3B-7DAE-4A50-8489-12C406482794 Q57177365-1E1A4462-1C6F-48B9-9C52-0A4B4CB02AB1 Q58768056-2BE3C1C0-8E0C-40D0-9FC4-99BFF6049927

P2860

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.

Item

http://www.wikidata.org/entity/Q38871799

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.

@en

type

Item

label

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.

@en

prefLabel

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.

@en

P1476

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

@en

P2093

Cristian Moiola

http://www.w3.org/2001/XMLSchema#string

Cristina Mirantes

http://www.w3.org/2001/XMLSchema#string

Eva Colàs

http://www.w3.org/2001/XMLSchema#string

Isidre Felip

http://www.w3.org/2001/XMLSchema#string

Maria Alba Dosil

http://www.w3.org/2001/XMLSchema#string

Maria Santacana

http://www.w3.org/2001/XMLSchema#string

Núria Eritja

http://www.w3.org/2001/XMLSchema#string

Sònia Gatius

http://www.w3.org/2001/XMLSchema#string

Xavier Matias-Guiu

http://www.w3.org/2001/XMLSchema#string

P2860

Cell cycle, CDKs and cancer: a changing paradigm

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice

One mouse, one patient paradigm: New avatars of personalized cancer therapy

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

Targeting CDK4 and CDK6: From Discovery to Therapy

Cell cycle kinases in cancer

Integrated genomic characterization of endometrial carcinoma

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

Pten is essential for embryonic development and tumour suppression

P304

152-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.4896

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

242

http://www.w3.org/2001/XMLSchema#string

P50

Mario Encinas

Joan Antoni Schoenenberger

Eloi Garí

Raúl Navaridas

Xavier Dolcet

P577

2017-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28349562

http://www.w3.org/2001/XMLSchema#string

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.

about

P2860

P2860

Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698